Anal Cancer Incidence and Survival: Comparing the Greater San-Francisco Bay Area to Other SEER Cancer Registries

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Amirian, E Susan ^a   Fickey, Paul A ^a   Scheurer, Michael E ^a   Chiao, Elizabeth Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ANUS CANCER; ARTICLE; ASIAN; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; LYMPH NODE METASTASIS; MALE; PATIENT SURVIVAL; PROBABILITY; SEX; SQUAMOUS CELL CARCINOMA; SURVEILLANCE EPIDEMIOLOGY AND END RESULTS; SURVIVAL; SURVIVAL TIME; TUMOR LOCALIZATION; UNITED STATES;

EID: 84874637981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058919     Document Type: Article

References (23)

1. Clark MA, Hartley A, Geh JI, (2004) Cancer of the anal canal. Lancet Oncol 5: 149-157.
2. Nielsen A, Munk C, Kjaer SK, (2012) Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer 130: 1168-1173.
3. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, et al. (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13: 487-500.
4. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H, (2006) Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 43: 223-233.
5. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR, (2004) Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101: 281-288.
6. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2012) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute. Available: http://seercancergov/csr/1975_2009_pops09.
7. Chiao EY, Krown SE, Stier EA, Schrag D, (2005) A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 40: 451-455.
8. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, et al. (2001) Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 93: 843-849.
9. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, et al. (2012) Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 54: 1026-1034.
10. Palefsky JM, Holly EA, Ralston ML, Jay N, (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177: 361-367.
11. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM, (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59-67.
12. Shiels MS, Cole SR, Kirk GD, Poole C, (2009) A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 52: 611-622.
13. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC, (2009) Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 52: 203-208.
14. Palefsky J, Berry JM, Jay N (2012) Anal cancer screening. Lancet Oncol 13: e279-280; author rreply e280.
15. D'Souza G, Cook RL, Ostrow D, Johnson-Hill LM, Wiley D, et al. (2008) Anal cancer screening behaviors and intentions in men who have sex with men. J Gen Intern Med 23: 1452-1457.
16. Chin-Hong PV, Palefsky JM, (2005) Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther 18: 67-76.
17. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM, (2000) Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 108: 634-641.
18. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, et al. (1999) The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281: 1822-1829.
19. Palefsky JM, Rubin M, (2009) The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am 36: 187-200.
20. UCSF Department of Medicine Anal Cancer Information, Complete List of HRA Providers. Available: http://id.medicine.ucsf.edu/analcancerinfo/all_providers.html. Accessed: 2012 1 July 1.
21. National Cancer Institute S, Epidemiology, and End Results (SEER) Program About SEER. Available: http://seer.cancer.gov/about/. Accessed 2012 June 12.
22. Daibata M, Taguchi T, Kamioka M, Kubonishi I, Taguchi H, et al. (1998) Identification of integrated human herpesvirus 6 DNA in early pre-B cell acute lymphoblastic leukemia. Leukemia 12: 1002-1004.
23. Chin-Hong PV, Berry JM, Cheng SC, Catania JA, Da Costa M, et al. (2008) Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 149: 300-306.